T1	Participants 95 109	schizophrenia:
T2	Participants 294 308	schizophrenia.
T3	Participants 473 501	patients with schizophrenia.
T4	Participants 502 604	Sixteen schizophrenia patients with predominantly negative symptoms on stable antipsychotic medication
